Improving hands-free speech rehabilitation in laryngectomized patients – proof-of-concept of a novel intratracheal fixation device

Permanent hands-free speech with the use of an automatic speaking valve (ASV) is regarded as the optimal voice rehabilitation after total laryngectomy. Due to fixation problems, regular ASV use in patients with a laryngectomy is limited. We have developed an intratracheal fixation device (ITFD) composed of an intratracheal button augmented by hydrophilic foam around its shaft. This study evaluates the short-term effectiveness and experienced comfort of this ITFD during hands-free speech in 7 participants with a laryngectomy. We found that 4 of 7 participants had secure ASV fixation inside the tracheostoma during hands-free speech for at least 30 minutes with the ITFD. The ITFD’s comfort was perceived positively overall. The insertion was perceived as being mildly uncomfortable but not painful. This proof-of-concept study demonstrates the feasibility of the ITFD that might improve stomal attachment of ASVs, and it provides the basis for further development toward a prototype suitable for long-term daily use

Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial

BACKGROUND AND PURPOSE: Magnesium reverses cerebral vasospasm and reduces infarct volume after experimental subarachnoid hemorrhage (SAH) in rats. We aimed to assess whether magnesium reduces the frequency of delayed cerebral ischemia (DCI) in patients with aneurysmal SAH. METHODS: Patients were randomized within 4 days after SAH. Magnesium sulfate therapy consisted of a continuous intravenous dose of 64 mmol/L per day, to be started within 4 days after SAH and continued until 14 days after occlusion of the aneurysm. The primary outcome DCI (defined as the occurrence of a new hypodense lesion on computed tomography compatible with clinical features of DCI) was analyzed according to the "on-treatment" principle. For the secondary outcome measures "poor outcome" (Rankin >3) and "excellent outcome" (Rankin 0), we used the "intention-to-treat" principle. RESULTS: A total of 283 patients were randomized. Magnesium treatment reduced the risk of DCI by 34% (hazard ratio, 0.66; 95% CI, 0.38 to 1.14). After 3 months, the risk reduction for poor outcome was 23% (risk ratio, 0.77; 95% CI, 0.54 to 1.09). At that time, 18 patients in the treatment group and 6 in the placebo group had an excellent outcome (risk ratio, 3.4; 95% CI, 1.3 to 8.9). CONCLUSIONS: This study suggests that magnesium reduces DCI and subsequent poor outcome, but the results are not yet definitive. A next step should be a phase III trial to confirm the beneficial effect of magnesium therapy, with poor outcome as primary outcom

Late neurocognitive sequelae in patients with WHO grade I meningioma

BACKGROUND: Information on the neurocognitive outcome following treatment of benign meningiomas is virtually lacking. This is remarkable considering these patientsś survival is the most favorable of all intracranial tumors. The aim of the present study is therefore to document the extent and nature of neurocognitive deficits in WHO grade I meningioma patients after treatment. METHODS: Eighty-nine WHO grade I meningioma patients who underwent surgery with or without adjuvant radiotherapy were individually matched to 89 healthy controls for age, sex, and educational level. Neurocognitive functioning of patients was assessed at least one year following treatment and compared to that of healthy controls using Student's t-tests. Additionally, associations between tumor characteristics (size, lateralization and localization), treatment characteristics (radiotherapy), and epilepsy burden (based on seizure frequency and antiepileptic drug use) and neurocognitive functioning were investigated. RESULTS: Compared to healthy controls meningioma patients showed significant impairments in executive functioning (p < 0.001), verbal memory (p < 0.001), information processing capacity (p = 0.001), psychomotor speed (p = 0.001), and working memory (p = 0.006). Patients with skull base meningiomas performed significantly lower on three out of six neurocognitive domains when compared to convexity meningiomas. Left-sided as opposed to right sided meningiomas were related to verbal memory deficits. A higher epilepsy burden was significantly associated with lower executive functioning, which primarily could be attributed to antiepileptic drug use. No significant associations were established between neurocognitive status and radiotherapy or tumor volume. CONCLUSIONS: Meningioma patients are characterized by long-term deficits in neurocognitive functioning that can partly be attributed to the use of antiepileptic drugs and tumor location, but not to the use of radiotherap

National land use specific reference values: a basis for maximum values in Dutch soil policy

The National Institute for Public Health and the Environment has derived Reference Values for maximum permissible soil pollution. The Netherlands Ministry of Housing, Spatial Planning and the Environment (VROM) used these values as a basis for the maximum values for soil pollution. The ministry set these values down according to a proposal for an update of soil policy and the Soil Protection Act in 2003. Reference values refer to allowed concentrations of pollutants in soil, depending on the land use. The soil concentrations of pollutants with values below these concentrations meet all the requirements. The risks for humans, the ecosystem and agriculture were analyzed as critical factors, with risk thresholds derived for different types of land use, such as playgrounds, gardens, and agricultural and nature areas. Furthermore, an accelerated procedure was used to compile a complete list of reference values in 2006. The RIVM used state-of-the-art knowledge to complete the 'old' knowledge for information on toxicity of substances; figures were used where knowledge gaps occurred. A recommendation for the coming years is to address resulting inconsistencies in the list of reference values.Het RIVM heeft de referentiewaarden afgeleid waarmee het ministerie van VROM de maximaal toelaatbare bodemverontreinigingen onderbouwt (maximale waarden). Het ministerie heeft deze normen ingesteld in lijn met zijn voorstel uit 2003 om het bodembeleid en de Wet bodembescherming te actualiseren. Referentiewaarden zijn concentraties van verontreinigende stoffen in de bodem die, afhankelijk van het bodemgebruik, zijn toegestaan. Onder deze concentraties voldoet de bodem aan alle eisen. Voor verschillende vormen van bodemgebruik, zoals landbouw, kinderspeelplaatsen of industrie, zijn grensgehalten voor risico's bepaald. Dat zijn bijvoorbeeld, afhankelijk van het gebruik, risico's voor de mens, voor het ecosysteem en voor de landbouw. Het RIVM heeft gebruikgemaakt van een versnelde procedure om in 2006 een compleet voorstel van referentiewaarden gereed te hebben. Die snelheid was ingegeven door de werkgroep NOBO (normstelling en bodemkwaliteitsbeoordeling). Deze werkgroep heeft tevens uitgangspunten en beslissingen geformuleerd op basis waarvan het RIVM de referentiewaarden heeft afgeleid. Het RIVM heeft voor zijn onderzoek zo veel mogelijk gebruikgemaakt van de nieuwste kennis en inzichten, voor zover die beschikbaar zijn. Deze informatie is aangevuld met 'oude' kennis over stoffen. Deze combinatie heeft evenwel tot inconsistenties geleid in de afleiding van referentiewaarden. Het RIVM beveelt daarom aan de komende jaren aandacht te besteden aan de inconsistenties en zwakke plekken van de referentiewaarden

Gender balance and suitable positive actions to promote gender equality among healthcare professionals in neuro-oncology:The EANO positive action initiative

Background:The proportion of women among healthcare and biomedical research professionals in neuro-oncology is growing. With changes in cultural expectations and work-life balance considerations, more men aspire to nonfull-time jobs, yet, leadership positions remain dominated by men.Methods:The European Association of Neuro-Oncology (EANO) disparity committee carried out a digital survey to explore gender balance and actions suitable to promote gender equality. The survey was distributed among EANO members in 2021, with responses analyzed descriptively.Results:In total, 262 participants completed the survey (141 women, 53.8%; median age 43). Respondents were neurosurgeons (68, 26.0%); neurologists (67, 25.6%), medical oncologists (43, 16.4%), or other healthcare or research professionals; 208 participants (79.4%) worked full-time. Positive action to enforce the role of women in neuro-oncology was deemed necessary by 180 participants (68.7%), but only 28 participants (10.7%) agreed that women only should be promoted until gender balance is reached. A majority of respondents (162, 61.8%) felt that women with an equivalent CV should be prioritized over men to reach gender balance. If in the future the balance favored women at higher positions, 112 respondents (42.7%) agreed to apply positive action for men. The top indicators considered relevant to measure gender balance were: salary for similar positions (183/228, 80.3%), paid overtime (176/228, 77.2%), number of permanent positions (164/228, 71.9%), protected time for research (161/227, 70.9%), and training opportunities (157/227, 69.2%).Conclusions:Specific indicators may help to measure and promote gender balance and should be considered for implementation among healthcare professionals in neuro-oncology

The feasibility and added value of mapping music during awake craniotomy:A systematic review

The value of mapping musical function during awake craniotomy is unclear. Hence, this systematic review was conducted to examine the feasibility and added value of music mapping in patients undergoing awake craniotomy. An extensive search, on 26 March 2021, in four electronic databases (Medline, Embase, Web of Science and Cochrane CENTRAL register of trials), using synonyms of the words “Awake Craniotomy” and “Music Performance,” was conducted. Patients performing music while undergoing awake craniotomy were independently included by two reviewers. This search resulted in 10 studies and 14 patients. Intra‐operative mapping of musical function was successful in 13 out of 14 patients. Isolated music disruption, defined as disruption during music tasks with intact language/speech and/or motor functions, was identified in two patients in the right superior temporal gyrus, one patient in the right and one patient in the left middle frontal gyrus and one patient in the left medial temporal gyrus. Pre‐operative functional MRI confirmed these localizations in three patients. Assessment of post‐operative musical function, only conducted in seven patients by means of standardized (57%) and non‐standardized (43%) tools, report no loss of musical function. With these results, we conclude that mapping music is feasible during awake craniotomy. Moreover, we identified certain brain regions relevant for music production and detected no decline during follow‐up, suggesting an added value of mapping musicality during awake craniotomy. A systematic approach to map musicality should be implemented, to improve current knowledge on the added value of mapping musicality during awake craniotomy